Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation (Q45835): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Revision as of 14:04, 13 August 2026
A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KA87.2 |
||
| English | Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation |
A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother. |
Statements
CID11:KA87.2
0 references
dki-india-KA87.2
0 references
Concluído
0 references
13 August 2026
0 references
